Skip to Content

APO LE 20 (Leflunomide 20 mg)

Pill imprint APO LE 20 has been identified as Leflunomide 20 mg.

Leflunomide is used in the treatment of rheumatoid arthritis; psoriatic arthritis and belongs to the drug classes antirheumatics, selective immunosuppressants. Not for use in pregnancy. Leflunomide 20 mg is not a controlled substance under the Controlled Substance Act (CSA).

Leflunomide 20 mg APO LE 20
Leflunomide 20 mg APO LE 20
Leflunomide 20 mg APO LE 20
Leflunomide 20 mg APO LE 20 Front
Leflunomide 20 mg APO LE 20 Back
Leflunomide
Imprint:
APO LE 20
Strength:
20 mg
Color:
White
Shape:
Three-sided
Availability:
Prescription only
Drug Class:
Antirheumatics
Selective immunosuppressants
Pregnancy Category:
X - Not for use in pregnancy
CSA Schedule:
Not a controlled drug
Manufacturer:
Apotex Corp.
National Drug Code (NDC):
60505-2503
Inactive Ingredients:
lactose anhydrous
silicon dioxide
crospovidone
magnesium stearate
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
60429-0320 Golden State Medical Supply (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide